文献速递淋巴瘤

利用捕获Hi-C鉴定B细胞淋巴瘤中反复出现的非编码突变

Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
PubMed 文献 · Blood Adv · 2019-01-01

该研究对117例B细胞淋巴瘤患者进行全基因组测序,利用初始B细胞中的启动子捕获Hi-C数据定义顺式调控元件,从中搜寻驱动突变。研究发现调控区突变可显著改变基因表达,包括靶向CD69、IGLL5和MMP14的顺式调控元件拷贝数变异及TPRG1顺式调控元件的单核苷酸变异,并揭示编码与非编码突变靶向通路的共通性,如调控Notch信号的MMP14。

要点

  • 对117例B细胞淋巴瘤患者全基因组测序分析非编码基因组。
  • 利用初始B细胞启动子捕获Hi-C定义顺式调控元件以搜寻驱动突变。
  • 发现调控区突变显著改变基因表达,涉及CD69、IGLL5、MMP14和TPRG1。

核心结论

  • 本研究增进了对淋巴瘤发生的理解,并展示了利用染色体构象捕获技术解读与癌症生物学相关的非编码突变的优势。

研究设计与样本

  • 研究分析了117例B细胞淋巴瘤患者的全基因组测序数据,并使用初始B细胞中的启动子捕获Hi-C数据定义顺式调控元件。

主要发现

  • 研究识别出突变显著改变基因表达的调控区域,包括靶向CD69、IGLL5和MMP14的顺式调控元件拷贝数变异,以及TPRG1顺式调控元件中的单核苷酸变异。
  • 研究显示编码和非编码突变靶向的通路具有共通性,例如调控Notch信号的MMP14,Notch信号通路在淋巴瘤发生中重要且其表达与患者生存相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The identification of driver mutations is fundamental to understanding oncogenesis. Although genes frequently mutated in B-cell lymphoma have been identified, the search for driver mutations has largely focused on the coding genome. Here we report an analysis of the noncoding genome using whole-genome sequencing data from 117 patients with B-cell lymphoma. Using promoter capture Hi-C data in naive B cells, we define cis-regulatory elements, which represent an enriched subset of the noncoding genome in which to search for driver mutations. Regulatory regions were identified whose mutation significantly alters gene expression, including copy number variation at cis-regulatory elements targeting CD69, IGLL5, and MMP14, and single nucleotide variants in a cis-regulatory element for TPRG1 We also show the commonality of pathways targeted by coding and noncoding mutations, exemplified by MMP14, which regulates Notch signaling, a pathway important in lymphomagenesis and whose expression is associated with patient survival. This study provides an enhanced understanding of lymphomagenesis and describes the advantages of using chromosome conformation capture to decipher noncoding mutations relevant to cancer biology.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Cornish AJ, Hoang PH, Dobbins SE, et al. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C. Blood Adv. 2019. PMID: 30606723. doi:10.1182/bloodadvances.2018026419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。